Klomipramin Viatris

Clomipramine, the active ingredient in Klomipramin Viatris, is a tricyclic antidepressant presented as an oral dosage form for oral use. It treats obsessive‑compulsive disorder, major depressive disorder, panic disorder, and depressive symptoms associated with chronic pain in adults.

GNH USA supplies Klomipramin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klomipramin Viatris, a tricyclic antidepressant, is used in several psychiatric and pain‑related conditions. - Obsessive‑Compulsive Disorder: reduces intrusive thoughts and compulsive behaviors. - Major Depressive Disorder: alleviates depressive mood, loss of interest, and related symptoms. - Panic Disorder: decreases the frequency and severity of panic attacks. - Depressive symptoms associated with chronic pain: improves mood in patients experiencing chronic pain.

Clomipramin Viatris may cause a range of adverse reactions.

Common Side Effects: - Dry mouth - Drowsiness - Constipation - Weight gain

Serious or Rare Side Effects: - Cardiac arrhythmias - Seizures - Serotonin syndrome

Before prescribing or dispensing Klomipramin Viatris, consider the following safety measures. - Assess cardiac history: evaluate risk of arrhythmias before initiating therapy. - Monitor for suicidal ideation: especially during the early treatment phase. - Avoid abrupt discontinuation: taper the dose to prevent withdrawal symptoms. - Use caution in patients with glaucoma: anticholinergic effects may worsen intra‑ocular pressure. - Store at room temperature: keep in the original container, protect from moisture and light.

Clomipramin Viatris can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may precipitate hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, triptans): increased risk of serotonin syndrome.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., fluoxetine): may raise clomipramine plasma levels. - CNS depressants (alcohol, benzodiazepines): additive sedation and respiratory depression. - Anticholinergic drugs: combined anticholinergic burden can exacerbate dry mouth, constipation, and blurred vision.